Minimally invasive liver resection in metabolic syndrome: insights and future directions.
作者信息
Wang Kechun, Li Yifan, Gong Jinbo, Wang Mingda, Yang Tian
机构信息
Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University (Naval Medical University), Shanghai, China.
Department of Hepatobiliary Surgery, Affiliated Hospital of Nantong University, Nantong, China.
出版信息
Hepatobiliary Surg Nutr. 2024 Aug 1;13(4):703-705. doi: 10.21037/hbsn-24-294. Epub 2024 Jul 18.
Abstract
摘要
相似文献
1
Minimally invasive liver resection in metabolic syndrome: insights and future directions.代谢综合征中的微创肝切除术：见解与未来方向。
Hepatobiliary Surg Nutr. 2024 Aug 1;13(4):703-705. doi: 10.21037/hbsn-24-294. Epub 2024 Jul 18.
2
Minimally invasive liver resection for metastatic colorectal cancer: a multi-institutional, international report of safety, feasibility, and early outcomes.转移性结直肠癌的微创肝切除术：一项多机构、国际范围的安全性、可行性及早期结果报告。
Ann Surg. 2009 Nov;250(5):842-8. doi: 10.1097/SLA.0b013e3181bc789c.
3
Does minimally invasive liver resection improve long-term survival compared to open resection for hepatocellular carcinoma? A systematic review and meta-analysis.与开放性肝切除术相比，微创肝切除术是否能提高肝细胞癌的长期生存率？系统评价和荟萃分析。
Scand J Surg. 2022 Jan-Mar;111(1):14574969211042455. doi: 10.1177/14574969211042455. Epub 2021 Oct 3.
4
Robotic-assisted minimally invasive liver resection.机器人辅助微创肝切除术
Asian J Surg. 2014 Apr;37(2):53-7. doi: 10.1016/j.asjsur.2014.01.015. Epub 2014 Mar 15.
5
A Literature Review to Assess Blood Loss in Minimally Invasive Liver Surgery Versus in Open Liver Resection.一项评估微创肝脏手术与开放性肝切除术中失血情况的文献综述。
Cureus. 2021 Jun 28;13(6):e16008. doi: 10.7759/cureus.16008. eCollection 2021 Jun.
6
Robotic hepatectomy: current evidence and future directions.机器人肝切除术：当前证据与未来方向。
Minerva Surg. 2023 Oct;78(5):525-536. doi: 10.23736/S2724-5691.23.09858-1. Epub 2023 Mar 21.
7
Precise hepatectomy guided by minimally invasive surgery: a novel strategy for liver resection.微创手术引导下的精准肝切除术：一种肝切除的新策略。
Hepatogastroenterology. 2012 Sep;59(118):1951-9. doi: 10.5754/hge10815.
8
Experience with more than 500 minimally invasive hepatic procedures.拥有超过500例微创肝脏手术的经验。
Ann Surg. 2008 Sep;248(3):475-86. doi: 10.1097/SLA.0b013e318185e647.
9
Perioperative and oncologic outcomes of minimally invasive liver resection for colorectal metastases: A case-control study of 130 patients.结直肠癌肝转移微创肝切除的围手术期及肿瘤学结局：130例患者的病例对照研究
Surgery. 2016 Oct;160(4):1097-1103. doi: 10.1016/j.surg.2016.04.043. Epub 2016 Jul 30.
10
Impact of neoadjuvant chemotherapy on short-term outcomes after simple and complex minimally invasive minor hepatectomy for colorectal liver metastases: A propensity-score matched and coarsened exact matched study.新辅助化疗对结直肠癌肝转移单纯及复杂微创小肝切除术短期结局的影响：倾向评分匹配和粗化精确匹配研究。
Eur J Surg Oncol. 2024 Jun;50(6):108309. doi: 10.1016/j.ejso.2024.108309. Epub 2024 Apr 2.
本文引用的文献
1
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据：全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
2
Propensity Score-Matching Analysis Comparing Robotic Versus Laparoscopic Limited Liver Resections of the Posterosuperior Segments: An International Multicenter Study.倾向评分匹配分析比较后上段有限肝切除术的机器人手术与腹腔镜手术：一项国际多中心研究。
Ann Surg. 2024 Feb 1;279(2):297-305. doi: 10.1097/SLA.0000000000006027. Epub 2023 Jul 24.
3
Minimally Invasive Versus Open Liver Resections for Hepatocellular Carcinoma in Patients With Metabolic Syndrome.代谢综合征患者的微创与开腹肝切除术治疗肝细胞癌的比较。
Ann Surg. 2023 Nov 1;278(5):e1041-e1047. doi: 10.1097/SLA.0000000000005861. Epub 2023 Mar 30.
4
Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment.非酒精性脂肪性肝炎相关肝细胞癌：发病机制与治疗。
Nat Rev Gastroenterol Hepatol. 2023 Aug;20(8):487-503. doi: 10.1038/s41575-023-00754-7. Epub 2023 Mar 17.
5
Indications, trends, and perioperative outcomes of minimally invasive and open liver surgery in non-obese and obese patients: An international multicentre propensity score matched retrospective cohort study of 9963 patients.非肥胖和肥胖患者微创与开腹肝手术的适应证、趋势和围手术期结局：一项国际多中心倾向评分匹配回顾性队列研究纳入 9963 例患者。
Int J Surg. 2022 Nov;107:106957. doi: 10.1016/j.ijsu.2022.106957. Epub 2022 Oct 14.
6
ASO Author Reflections: Effect of Preoperative Metabolic Syndrome for Patients with Hepatocellular Carcinoma.ASO作者反思：术前代谢综合征对肝细胞癌患者的影响。
Ann Surg Oncol. 2023 Jan;30(1):359-360. doi: 10.1245/s10434-022-12557-2. Epub 2022 Sep 19.
7
Association of Concurrent Metabolic Syndrome with Long-term Oncological Prognosis Following Liver Resection for Hepatocellular Carcinoma Among Patients with Chronic Hepatitis B Virus Infection: A Multicenter Study of 1753 Patients.慢性乙型肝炎病毒感染患者中，代谢综合征与肝细胞癌肝切除术后长期肿瘤学预后的关联：一项对1753例患者的多中心研究
Ann Surg Oncol. 2023 Jan;30(1):346-358. doi: 10.1245/s10434-022-12529-6. Epub 2022 Sep 16.
8
Operative and long-term oncologic outcomes of laparoscopic versus open major liver resection in patients with a high body mass index (> 25 kg/m): a propensity score matching analysis.腹腔镜与开腹肝切除术治疗高体重指数（> 25kg/m²）患者的手术和长期肿瘤学结果：倾向评分匹配分析。
Surg Endosc. 2022 Aug;36(8):5772-5783. doi: 10.1007/s00464-022-09114-z. Epub 2022 Mar 17.
9
Multicenter Propensity Score-Based Study of Laparoscopic Repeat Liver Resection for Hepatocellular Carcinoma: A Subgroup Analysis of Cases with Tumors Far from Major Vessels.基于倾向评分的多中心肝细胞癌腹腔镜重复肝切除术研究：远离主要血管肿瘤病例的亚组分析
Cancers (Basel). 2021 Jun 25;13(13):3187. doi: 10.3390/cancers13133187.
10
Laparoscopic and open liver resection for hepatocellular carcinoma with Child-Pugh B cirrhosis: multicentre propensity score-matched study.腹腔镜与开腹肝切除术治疗伴有 Child-Pugh B 级肝硬化的肝细胞癌：多中心倾向评分匹配研究。
Br J Surg. 2021 Mar 12;108(2):196-204. doi: 10.1093/bjs/znaa041.
Zotero 插件